Wolters Kluwer said it will divest its Pharma Solutions business unit, in two parts.
Brands now on the block include the PHAST syndicated prescription data service, plus the Adis R&D Insight and inThought pipeline analysis tools.
Pharma Solutions “no longer fits with the [company] growth strategy,” which is to focus spending and investment in core healthcare provider markets, Robert Dekker, VP of communications for Wolters Kluwer Health & Pharma Solutions, told MM&M.
Health brands that are staying include the Lippincott Williams & Wilkins textbooks and journals, and UpToDate web and mobile medical apps.
Officials expect to close a sale around, or shortly after, year's end. William Blair & Co. and Lazard Middle Market have been retained as advisors for separate sell-offs of the healthcare analytics and marketing & publishing services businesses, respectively.